⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17799154 | 0.85 | — | — | |
| SCHEMBL23630993 | 0.83 | — | — | |
| SCHEMBL2646953 | 0.78 | — | — | |
| SCHEMBL10877509 | 0.67 | TRIM24 (0.61) | — | |
| SCHEMBL8643330 | 0.65 | — | — | |
| SCHEMBL770814 | 0.65 | — | — | |
| SCHEMBL2485364 | 0.63 | TRIM24 (0.65) | — | |
| SCHEMBL5676445 | 0.63 | — | — | |
| SCHEMBL22164273 | 0.61 | TRIM24 (0.61) | — | |
| SCHEMBL119955 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970146-B1 | ACYLAMINOCYCLOALKYL COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF DOPAMINE D3 RECEPTOR | ABBVIE DEUTSCHLAND (DE) | 2017-11-01 | — | — | EP | claimed |
| EP-1776349-B1 | 2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) | JANSSEN PHARMACEUTICA NV (BE) | 2010-10-06 | — | — | EP | claimed |
| EP-1817287-B1 | AROMATIC ETHER DERIVATIVES USEFUL AS THROMBIN INHIBITORS | LILLY CO ELI (US) | 2010-02-10 | — | — | EP | claimed |
| EP-1606282-B1 | PHENYL- AND PYRIDYLPIPEREIDINYE-DERIVATIVES AS MODULATORS OF GLUCOSE METABOLISM | ARENA PHARM INC (US) | 2008-11-12 | — | — | EP | claimed |
| EP-1761542-B1 | OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS | HOFFMANN LA ROCHE (CH) | 2008-01-02 | — | — | EP | claimed |
| EP-0779888-B1 | PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM | BOEHRINGER INGELHEIM PHARMA (DE) | 1999-04-28 | — | — | EP | claimed |
| EP-0159784-B1 | CARBACYCLIN ANALOGUES | THE UPJOHN COMPANY (US) | 1989-06-07 | — | — | EP | claimed |
| JP-7181440-A | — | — | None | — | — | JP | disclosed |
| US-9890292-B2 | Sol-gel ink and method for producing same | SCHOTT AG (DE) | 2018-02-13 | — | — | US | disclosed |
| US-20150210871-A1 | SOL-GEL INK AND METHOD FOR PRODUCING SAME | SCHOTT AG (DE) | 2015-07-30 | — | — | US | disclosed |
| US-8703813-B2 | Compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same | SNU R & DB FOUNDATION (KR) | 2014-04-22 | — | — | US | disclosed |
| EP-2363400-B1 | NOVEL COMPOUND WITH SPIRO CHIRAL CARBON BACKBONE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | SNU R&DB FOUNDATION (KR) | 2013-06-12 | — | — | EP | disclosed |
| US-20110218240-A1 | NOVEL COMPOUND WITH SPIRO CHIRAL CARBON BACKBONE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | SNU R & DB FOUNDATION (KR) | 2011-09-08 | — | — | US | disclosed |
| EP-2363400-A2 | NOVEL COMPOUND WITH SPIRO CHIRAL CARBON BACKBONE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | SNU R&DB Foundation (KR) | 2011-09-07 | — | — | EP | disclosed |
| JP-H07181440-A | OPTICALLY ACTIVE COMPOUND, LIQUID CRYSTAL COMPOSITION CONTAINING THAT, LIQUID CRYSTAL ELEMENT USING THIS LIQUID CRYSTAL COMPOSITION, AND DISPLAY METHOD AND DISPLAY DEVICE USING THESE | CANON INC | 1995-07-21 | — | — | JP | disclosed |